We wanted to assess if the use of meloxicam for pain management during the virus infection could alter the model inherent neuronal cell loss (NeuN+ labeled cells) or proliferation (5-Brom-2′-deoxyuridin+ (BrdU) labeled cells). The gene discussed is RBFOX3; the disease is viral infectious disease.